Cardiology and COVID-19 | Cardiology | JN Learning | AMA Ed Hub [Skip to Content]
[Skip to Content Landing]

Cardiology and COVID-19

Educational Objective
To understand the risks associated with COVID-19 for those with underlying cardiovascular disease
1 Credit CME

The initial reports on the epidemiology of coronavirus disease 2019 (COVID-19) emanating from Wuhan, China, offered an ominous forewarning of the risks of severe complications in elderly patients and those with underlying cardiovascular disease, including the development of acute respiratory distress syndrome, cardiogenic shock, thromboembolic events, and death. These observations have been confirmed subsequently in numerous reports from around the globe, including studies from Europe and the US. The mechanisms responsible for this vulnerability have not been fully elucidated, but there are several possibilities. Some of these adverse consequences could reflect the basic fragility of older individuals with chronic conditions subjected to the stress of severe pneumonia similar to influenza infections. In addition, development of type 2 myocardial infarction related to increased myocardial oxygen demand in the setting of hypoxia may be a predominant concern, and among patients with chronic coronary artery disease, an episode of acute systemic inflammation might also contribute to plaque instability, thus precipitating acute coronary syndromes, as has also been reported during influenza outbreaks.

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

Article Information

Corresponding Author: Robert O. Bonow, MD, MS, Division of Cardiology, Northwestern University Feinberg School of Medicine, 676 N St Clair St, Ste 600, Chicago, IL 60611 (r-bonow@northwestern.edu).

Conflict of Interest Disclosures: None reported.

References
1.
Madjid  M , Safavi-Naeini  P , Solomon  SD , Vardeny  O .  Potential effects of coronaviruses on the cardiovascular system: a review.   JAMA Cardiol. 2020;5(7):831-840. doi:10.1001/jamacardio.2020.1286 PubMedGoogle ScholarCrossref
2.
Fosbøl  EL , Butt  JH , Østergaard  L ,  et al.  Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality.   JAMA. 2020;324(2):168-177. doi:10.1001/jama.2020.11301 PubMedGoogle ScholarCrossref
3.
Bikdeli  B , Madhavan  MV , Jimenez  D ,  et al; Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function.  COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy and follow-up.   J Am Coll Cardiol. 2020;75(23):2950-2973. doi:10.1016/j.jacc.2020.04.031 PubMedGoogle ScholarCrossref
4.
Shi  S , Qin  M , Shen  B ,  et al.  Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China.   JAMA Cardiol. 2020;5(7):802-810. doi:10.1001/jamacardio.2020.0950 PubMedGoogle ScholarCrossref
5.
Inciardi  RM , Lupi  L , Zaccone  G ,  et al.  Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19).   JAMA Cardiol. 2020;5(7):819-824. doi:10.1001/jamacardio.2020.1096 PubMedGoogle ScholarCrossref
6.
Puntmann  VO , Carerj  ML , Wieters  I ,  et al.  Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from COVID-19 illness.   JAMA Cardiol. Published online July 27, 2020. doi:10.1001/jamacardio.2020.3557PubMedGoogle Scholar
7.
Lindner  D , Fitzek  A , Bräuninger  H ,  et al.  Cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases.   JAMA Cardiol. Published online July 27, 2020. doi:10.1001/jamacardio.2020.3551 PubMedGoogle Scholar
8.
Lai  PH , Lancet  EA , Weiden  MD ,  et al.  Characteristics associated with out-of-hospital cardiac arrests and resuscitations during the novel coronavirus disease 2019 pandemic in New York City.   JAMA Cardiol. Published online June 19, 2020. doi:10.1001/jamacardio.2020.2488 PubMedGoogle Scholar
9.
Woolf  SH , Chapman  DA , Sabo  RT , Weinberger  DM , Hill  L .  Excess deaths from COVID-19 and other causes, March-April 2020.   JAMA. Published online July 1, 2020. doi:10.1001/jama.2020.11787 PubMedGoogle Scholar
10.
Gluckman  TJ , Wilson  MA , Chiu  ST ,  et al.  Case rates, treatment approaches, and outcomes in acute myocardial infarction during the coronavirus disease 2019 pandemic.   JAMA Cardiol. Published online August 7, 2020. doi:10.1001/jamacardio.2020.3629 PubMedGoogle Scholar
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_LoginSubscribe_Purchase
Close
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_LoginSubscribe_Purchase
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
Close
With a personal account, you can:
  • Track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
jn-learning_Modal_SaveSearch_NoAccess_Purchase
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close